IL17A and autoimmune disease: This raises the possibility that similar than targeting cytokines such as TNF-α [46], IL-12/23 [47], [48], IL-17 [49]–[51], or IL-21 [52] blocking of IL-9 might be of potential benefit in patients with psoriasis and other Th17 cell-mediated autoimmune diseases.